• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周神经母细胞瘤的病理学:未分化/低分化神经母细胞瘤中显著核仁的意义

Pathology of peripheral neuroblastic tumors: significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma.

作者信息

Tornóczky Tamás, Semjén Dávid, Shimada Hiroyuki, Ambros Inge M

机构信息

Department of Pathology, Pécs University, Medical School, Pécs, H-7643, Hungary.

出版信息

Pathol Oncol Res. 2007;13(4):269-75. doi: 10.1007/BF02940304. Epub 2007 Dec 25.

DOI:10.1007/BF02940304
PMID:18158560
Abstract

The presence of large cells having simultaneously increased cytoplasmic and nuclear volume accompanied by prominent nucleoli; i.e., differentiating neuroblasts and ganglion cells, is well documented in peripheral neuroblastic tumors (pNTs), and considered as one of the signs of tumor maturation and an indication of a better prognosis of the patients. On the other hand, in 2004 it was reported that large-cell neuroblastoma composed of neuroblastic cells with only nuclear enlargement without recognizable cytoplasmic maturation behaved poorly clinically. Here we are proposing a new pNT subtype in the neuroblastoma category, in addition to the undifferentiated, poorly differentiated and differentiating subtypes: that is large nucleolar neuroblastoma (LNN) characterized by large prominent nucleoli and no or very little amount of discernible cytoplasm. LNN, whose neuroblastic cells are often large in size due to nuclear enlargement, includes those tumors previously categorized into the large-cell neuroblastoma group. LNN tumors, regardless of the size of nuclei, seem to behave aggressively with a very poor prognosis of the patients. It is speculated that nucleolar enlargement without cytoplasmic maturation in LNN tumor cells can be a sign of MYCN amplification.

摘要

外周神经母细胞瘤(pNTs)中存在大细胞,其细胞质和细胞核体积同时增大,伴有明显的核仁,即分化中的神经母细胞和神经节细胞,这一点已有充分记录,并被视为肿瘤成熟的标志之一以及患者预后较好的指标。另一方面,2004年有报道称,由仅细胞核增大而无明显细胞质成熟的神经母细胞组成的大细胞神经母细胞瘤临床行为较差。除了未分化、低分化和分化型亚型外,我们在此提出神经母细胞瘤类别中的一种新的pNT亚型:即大核仁神经母细胞瘤(LNN),其特征是有大而明显的核仁且无或仅有极少量可辨别的细胞质。LNN的神经母细胞通常因细胞核增大而体积较大,包括那些先前归类为大细胞神经母细胞瘤组的肿瘤。LNN肿瘤,无论细胞核大小如何,似乎都具有侵袭性,患者预后极差。据推测,LNN肿瘤细胞中无细胞质成熟的核仁增大可能是MYCN扩增的标志。

相似文献

1
Pathology of peripheral neuroblastic tumors: significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma.外周神经母细胞瘤的病理学:未分化/低分化神经母细胞瘤中显著核仁的意义
Pathol Oncol Res. 2007;13(4):269-75. doi: 10.1007/BF02940304. Epub 2007 Dec 25.
2
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.增大且明显的核仁可能提示MYCN扩增:一项关于神经母细胞瘤(低雪旺细胞基质)、未分化/低分化亚型且有高有丝分裂-核溶解指数的研究。
Cancer. 2005 Jan 1;103(1):174-80. doi: 10.1002/cncr.20717.
3
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.外周神经母细胞瘤基因型-表型不一致:来自儿童肿瘤学组和国际神经母细胞瘤病理学委员会的报告。
Pediatr Blood Cancer. 2013 Mar;60(3):363-70. doi: 10.1002/pbc.24238. Epub 2012 Jun 28.
4
Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.大细胞神经母细胞瘤:一种具有侵袭性临床行为的神经母细胞瘤独特表型。
Cancer. 2004 Jan 15;100(2):390-7. doi: 10.1002/cncr.20005.
5
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.外周神经母细胞瘤中TrkA的表达:预后意义及生物学相关性
Cancer. 2004 Oct 15;101(8):1873-81. doi: 10.1002/cncr.20557.
6
Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.临床预后良好和不良组神经母细胞瘤(低施万细胞基质肿瘤)的形态学特征。
Cancer. 2002 Mar 1;94(5):1574-83. doi: 10.1002/cncr.10359.
7
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.用于外周神经母细胞瘤患者预后评估的国际神经母细胞瘤病理分类:儿童癌症研究组报告
Cancer. 2001 Nov 1;92(9):2451-61. doi: 10.1002/1097-0142(20011101)92:9<2451::aid-cncr1595>3.0.co;2-s.
8
Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.神经母细胞瘤性肿瘤超微结构特征的比较:从神经母细胞瘤到神经节神经瘤的成熟过程。
Ultrastruct Pathol. 1995 Jul-Aug;19(4):311-22. doi: 10.3109/01913129509064236.
9
Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.具有不一致基因型-表型关系的神经母细胞瘤:4例MYCN扩增且组织学表现良好的病例报告。
Pediatr Dev Pathol. 2011 Mar-Apr;14(2):87-92. doi: 10.2350/08-12-0579.1. Epub 2011 Feb 2.
10
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.通过组织病理学和N-myc分析联合鉴定神经母细胞瘤亚群
J Natl Cancer Inst. 1995 Oct 4;87(19):1470-6. doi: 10.1093/jnci/87.19.1470.

引用本文的文献

1
[Peripheral neuroblastic tumors in childhood].[儿童期周围神经母细胞瘤]
Pathologie (Heidelb). 2023 Nov;44(6):366-372. doi: 10.1007/s00292-023-01227-z. Epub 2023 Oct 11.
2
Adrenal Ganglioneuroblastoma of Adult Onset: A Literature Review.成人起病的肾上腺神经节神经母细胞瘤:文献综述
Cureus. 2023 Jan 3;15(1):e33288. doi: 10.7759/cureus.33288. eCollection 2023 Jan.
3
Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.长链非编码 RNA MYCNOS1 的沉默抑制了 MYCN 扩增的视网膜母细胞瘤的活性,而不依赖 RB1 突变。

本文引用的文献

1
c-myc overexpression causes anaplasia in medulloblastoma.c-myc过表达导致髓母细胞瘤间变。
Cancer Res. 2006 Jan 15;66(2):673-81. doi: 10.1158/0008-5472.CAN-05-1580.
2
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.增大且明显的核仁可能提示MYCN扩增:一项关于神经母细胞瘤(低雪旺细胞基质)、未分化/低分化亚型且有高有丝分裂-核溶解指数的研究。
Cancer. 2005 Jan 1;103(1):174-80. doi: 10.1002/cncr.20717.
3
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):8. doi: 10.1167/iovs.61.14.8.
4
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression.神经母细胞瘤中ARID1A缺失通过调节增强子介导的基因表达促进肾上腺素能向间充质转变。
Sci Adv. 2020 Jul 15;6(29):eaaz3440. doi: 10.1126/sciadv.aaz3440. eCollection 2020 Jul.
5
Replicating and identifying large cell neuroblastoma using high-dose intra-tumoral chemotherapy and automated digital analysis.采用大剂量瘤内化疗和自动化数字分析复制和鉴定神经母细胞瘤。
J Pediatr Surg. 2019 Dec;54(12):2595-2599. doi: 10.1016/j.jpedsurg.2019.08.022. Epub 2019 Aug 31.
6
MYCN induces neuroblastoma in primary neural crest cells.MYCN在原发性神经嵴细胞中诱导神经母细胞瘤。
Oncogene. 2017 Aug 31;36(35):5075-5082. doi: 10.1038/onc.2017.128. Epub 2017 May 1.
7
The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.前体核糖体RNA加工因子DEF是MYCN驱动的神经母细胞瘤发病机制中的限速因子。
Oncogene. 2017 Jul 6;36(27):3852-3867. doi: 10.1038/onc.2016.527. Epub 2017 Mar 6.
8
Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells.抑制缺氧诱导因子并联合全反式维甲酸治疗可增强神经母细胞瘤细胞的胶质细胞转分化。
Sci Rep. 2015 Jun 9;5:11158. doi: 10.1038/srep11158.
9
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.未分化型神经母细胞瘤,核仁明显形成的预后意义,以及 MYC/MYCN 蛋白表达:来自儿童肿瘤协作组的报告。
Cancer. 2013 Oct 15;119(20):3718-26. doi: 10.1002/cncr.28251. Epub 2013 Jul 30.
10
Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.骨髓中存在分化的神经母细胞是诊断时骨髓转移性神经母细胞瘤的有利预后因素。
Ann Lab Med. 2013 Mar;33(2):89-96. doi: 10.3343/alm.2013.33.2.89. Epub 2013 Feb 21.
髓母细胞瘤患者的组织病理学和分子细胞遗传学联合分层
Clin Cancer Res. 2004 Aug 15;10(16):5482-93. doi: 10.1158/1078-0432.CCR-03-0721.
4
Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.大细胞神经母细胞瘤:一种具有侵袭性临床行为的神经母细胞瘤独特表型。
Cancer. 2004 Jan 15;100(2):390-7. doi: 10.1002/cncr.20005.
5
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.国际神经母细胞瘤病理分类的修订:节细胞神经母细胞瘤,结节型中预后良好和不良亚组的确认。
Cancer. 2003 Nov 15;98(10):2274-81. doi: 10.1002/cncr.11773.
6
Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.临床预后良好和不良组神经母细胞瘤(低施万细胞基质肿瘤)的形态学特征。
Cancer. 2002 Mar 1;94(5):1574-83. doi: 10.1002/cncr.10359.
7
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.用于外周神经母细胞瘤患者预后评估的国际神经母细胞瘤病理分类:儿童癌症研究组报告
Cancer. 2001 Nov 1;92(9):2451-61. doi: 10.1002/1097-0142(20011101)92:9<2451::aid-cncr1595>3.0.co;2-s.
8
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.外周神经母细胞瘤患者的组织病理学(国际神经母细胞瘤病理分类)及MYCN状态:儿童癌症研究组报告
Cancer. 2001 Nov 15;92(10):2699-708. doi: 10.1002/1097-0142(20011115)92:10<2699::aid-cncr1624>3.0.co;2-a.
9
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis.N - 原癌基因增强了大量在核糖体生物合成和蛋白质合成中起作用的基因的表达。
EMBO J. 2001 Mar 15;20(6):1383-93. doi: 10.1093/emboj/20.6.1383.
10
The International Neuroblastoma Pathology Classification (the Shimada system).国际神经母细胞瘤病理分类(岛田系统)。
Cancer. 1999 Jul 15;86(2):364-72.